Back to
Man Group plc
REGNShowing 8 of 31 quarters
Position history for
Man Group plc's holdings in REGENERON PHARMACEUTICALS
Yes. Man Group holds 436,956 shares of REGN (Regeneron Pharmaceuticals), worth $272.5M, as of its Q2 2026 13F filing. It increased the position by 121,744 shares (+38.6%) from Q1 2026. Man Group has held REGN in every 13F on record since Q4 2018, 31 quarterly filings. REGN is 0.4% of Man Group's reported 13F portfolio.
Current Value
$272.5M
Current Shares
436,956
Total Value Change
+$208.8M
Total Shares Change
+376,435
Quarter-by-Quarter History
Other major holders of REGN: FMR LLC, VANGUARD GROUP INC